Investigating the Impact of Cancer Survivors' Experience on Rescuing Patients with Cancer
Design
Clinical trial with control group
Settings and conduct
At the first session, the test and control group is invited to introduce and complete the questionnaire. In this meeting, before the data are collected, the research objectives for the participants will be fully explained. The second, third, fourth and fifth sessions will be held with the experience of the survivors. At the sixth session, a separate intervention and control group will be invited to refer to the completed questionnaire to complete.
Participants/Inclusion and exclusion criteria
1. Conscious and written consent for participation in the study
2. Ability to attend meetings
3. Not having a history of other chronic diseases
4. Non-cancer in first-degree people
5. Age 60-20 years
6. Lack of participation in psychological training simultaneously
7. Getting involved in stage 2 or 3 cancer
Intervention groups
Patients participating in the research were randomly assigned to two groups of test (30 people) and control (30 people). Four survivors of cancer speak in a friendly and desirable environment based on their experiences of cancer, diagnosis, treatment, complications and self-care and adaptation to cancer, the effects of chemotherapy, nutrition, exercise, physical image, communication, and health issues. Patients in the test group participated in one of the four 120-minute training sessions once a week and are subject to an independent variable (surviving cancer). 20% of the final time of each session will be allocated to the free discussion. During this period, the control group will receive routine treatment.
Main outcome variables
resilience
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20180801040663N1
Registration date:2018-10-01, 1397/07/09
Registration timing:retrospective
Last update:2018-10-01, 1397/07/09
Update count:0
Registration date
2018-10-01, 1397/07/09
Registrant information
Name
Zahra Mollaei
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 5554 0021
Email address
mollaei-z@kaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-06-22, 1397/04/01
Expected recruitment end date
2018-09-21, 1397/06/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the effect of Cancer Survivors' experiences on resilience of cancer patients
Public title
Investigating the effect of Peer group experiences on resilience of cancer patients
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
1. Ability to participate in the sessions
Being involved in stage 2 or 3 cancer
Exclusion criteria:
having a history of other chronic diseases
have cancer in first-degree people
participating in psychological training simultaneously
Age
From 20 years old to 60 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
60
Randomization (investigator's opinion)
Randomized
Randomization description
Random assignment has been blocked so that first four blocks of letters A, B are prepared and randomly selected using the random numbers of numbers 1-6 and based on their choice, a sequence of letters A and B is correct and Each patient, according to the entry number to the plan, is one of the A and B breeds.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Other
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Kashan University of Medical Sciences and Health Services
Resiliency measure at the beginning of the study (before the intervention) and one month after the start of the study
Method of measurement
Connor and Davidson Resilience Questionnaire
Secondary outcomes
empty
Intervention groups
1
Description
The intervention group, Thirty patients, is selected to receive chemotherapy or radiotherapy, and then participate in four 90-minute sessions. At each session, there is a cancer survivor who will talk about his or her treatment experience. Assesment of this intervention will be carried out in the form of a pre-test and a Post-test.
Category
Rehabilitation
2
Description
Control group: The group continues to receive routine treatment, and will be selected only for this group of pre-test and post-test.